Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

FDA Committee Unanimous on Two Gene Therapies

Summary by Ground News
The FDA's Cellular, Tissue, and Gene Therapies advisory committee met June 9-10 to consider the two products. The votes each day were unanimously in favor of the products. If approved, beti-cel will be the first potentially curative gene therapy for transfusion-dependent beta-thalassemia.

3 Articles

MedscapeMedscape

FDA Committee Unanimous on Two Gene Therapies

An FDA advisory committee gave a unanimous thumbs up to two new gene therapies, one for beta-thalassemia and the other for a rare but fatal neurologic disorder.

·New York, United States
Read Full Article
N1N1

SNS Belgrade Committee unanimously endorses Šapic as mayor

The Belgrade Committee of the Serbian Progressive Party (SNS) unanimously decided today to nominate Aleksandar Shapic as mayor of the capital.

Read Full Article
ReadMagazineReadMagazine

FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy

FDA discussion of elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ReadMagazine broke the news on Monday, June 13, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Europe icon

Europe

FDA icon

FDA

Medical icon

Medical

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal